Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtre
1.
Braz. j. med. biol. res ; 34(6): 753-7, Jun. 2001. tab, ilus
Article Dans Anglais | LILACS | ID: lil-285848

Résumé

Helicobacter pylori (HP) infection is endemic worldwide. The proposed treatment is expensive and there are few reports regarding reinfection rates in Brazil. The aim of this study was to compare the eradication rates obtained with two therapeutic options and to evaluate reinfection one year after treatment. This was a prospective randomized trial with 55 patients. Thirty-nine patients had active duodenal ulcer (DU) and 16 non-ulcer dyspepsia (NUD), and all tested positive for HP. Diagnosis was based on at least two positive tests: ultrarapid urease test, histology and/or culture. Patients were randomized to two groups: group OMC treated with 40 mg omeprazole (once a day), 500 mg metronidazole and 250 mg clarithromycin (twice daily) for 7 days, or group NA treated with 300 mg nizatidine (once a day) and 1000 mg amoxicillin (twice daily) for 14 days. Those patients in whom HP was eradicated were followed up for one year to evaluate reinfection. Twenty-five patients were randomized for OMC and 30 for NA. HP eradication occurred in 20/25 patients (80 per cent) treated with OMC and 13/30 (43 per cent) treated with NA (P = 0.01). After reallocation because of initial treatment failure, the overall eradication rate was 44/51 patients (86 per cent). After an average follow-up of one year, we evaluated 34 patients (23 with DU and 11 with NUD). Reinfection occurred in 3/34 patients (7.6 per cent). We conclude that OMC is effective for HP eradication, and that NA should not be used. Reinfection occurs in 7.6 per cent of the patients in the first year after eradication.


Sujets)
Humains , Mâle , Femelle , Adolescent , Adulte , Adulte d'âge moyen , Ulcère duodénal/traitement médicamenteux , Dyspepsie/traitement médicamenteux , Infections à Helicobacter/traitement médicamenteux , Helicobacter pylori , Amoxicilline/usage thérapeutique , Antibactériens/usage thérapeutique , Anti-infectieux/usage thérapeutique , Antiulcéreux/usage thérapeutique , Clarithromycine/usage thérapeutique , Association de médicaments , Ulcère duodénal/microbiologie , Dyspepsie/microbiologie , Métronidazole/usage thérapeutique , Nizatidine/usage thérapeutique , Oméprazole/usage thérapeutique , Pénicillines/usage thérapeutique , Études prospectives , Récidive , Facteurs temps , Résultat thérapeutique
3.
Braz. j. med. biol. res ; 29(11): 1455-9, Nov. 1996. ilus
Article Dans Anglais | LILACS | ID: lil-187205

Résumé

Biliary and pancreatic stents are effective tools in the management of obstructive jaundice (both malignant and benign), pancreatic pseudocyst drainage, and as treatment for biliary and pancreatic fistulae. Unfortunately, stents may become blocked and require replacement in a number of patients. In the present study a blocked stent from a patient with transpapillary drainage of pancreatic pseudocyst and another from a patient with obstructive jaundice resulting from cancer of the head of the pancreas associated with Mirizzi syndrome were characterized by electron microscopy. Stent blockage was diagnosed by a pressure test and stent cultures were performed. Electron microscopy of the blocked stents revealed the sludge to consist of microcolonies of bacteria mixed with amorphous material, and cultures of both stents were positive for Klebsiella sp and E. coli.


Sujets)
Adulte , Femelle , Humains , Cholestase/complications , Escherichia coli/pathogénicité , Klebsiella/pathogénicité , Pancréatite alcoolique/complications , Endoprothèses/effets indésirables
4.
GED gastroenterol. endosc. dig ; 11(3): 131-2, jul.-set. 1992.
Article Dans Portugais | LILACS | ID: lil-197722

Résumé

Pseudomixoma de peritónio , uma patologia para que se manifesta por implantes de mucina na cavidade peritoneal decorrentes de tumor de ov rio ou apêndice. Os autores relatam um caso e fazem revisäo de literatura.


Sujets)
Humains , Mâle , Sujet âgé , Tumeurs du péritoine/diagnostic , Pseudomyxome péritonéal/diagnostic , Tumeurs du péritoine/chirurgie , Pseudomyxome péritonéal/chirurgie
5.
Rev. Hosp. Säo Paulo Esc. Paul. Med ; 1(2): 65-8, Jun. 1989. ilus, tab
Article Dans Anglais | LILACS | ID: lil-188363

Résumé

The presence of Campylobacter pylori in gastric mucosa of patients with dyspeptic complaints has been described. The association of the symptoms and endoscopic and histopathologic alterations with the presence of the bacterium still remains unknown. 117 patients were studied with respect to dyspeptic symptoms, endoscopic and histopathologic examinations, microbiological analysis and urease test to detect Campylobacter pylori. Campylobacter pylori was found in 77 per cent of all patients. Of these 36.8 per cent had normal gastric mucosa and 84.7 per cent presented gastritis. There was no association between the symptoms, the endoscopic and histological findings.


Sujets)
Humains , Mâle , Femelle , Enfant d'âge préscolaire , Enfant , Adolescent , Adulte , Adulte d'âge moyen , Dyspepsie/microbiologie , Helicobacter pylori/isolement et purification , Sujet âgé de 80 ans ou plus
SÉLECTION CITATIONS
Détails de la recherche